Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

VOR – vor biopharma inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VOR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
04:11 pm
vor
Form 424B3 Vor Biopharma Inc.
Low Report
Form 424B3 Vor Biopharma Inc.
Report
11/18
04:30 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
High Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Report
11/14
06:13 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
11/12
07:03 am
vor
Form 8-K Vor Biopharma Inc. For: Nov 10
Low Report
Form 8-K Vor Biopharma Inc. For: Nov 10
Report
11/12
06:08 am
vor
Form 424B5 Vor Biopharma Inc.
Neutral Report
Form 424B5 Vor Biopharma Inc.
Report
11/10
04:26 pm
vor
Form 424B5 Vor Biopharma Inc.
High Report
Form 424B5 Vor Biopharma Inc.
Report
11/10
04:24 pm
vor
Form S-3/A Vor Biopharma Inc.
High Report
Form S-3/A Vor Biopharma Inc.
Report
11/7
11:14 am
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: FMR LLC
Low Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: FMR LLC
Report
11/5
04:15 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Medium Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Report
11/3
08:02 am
vor
Form 8-K Vor Biopharma Inc. For: Nov 02
Medium Report
Form 8-K Vor Biopharma Inc. For: Nov 02
Report
10/30
06:42 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
10/30
06:41 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 28 Filed by: Kolchinsky Peter
Low Report
Form 4 Vor Biopharma Inc. For: Oct 28 Filed by: Kolchinsky Peter
Report
10/28
04:37 pm
vor
Form 8-K Vor Biopharma Inc. For: Oct 28
Medium Report
Form 8-K Vor Biopharma Inc. For: Oct 28
Report
10/27
08:07 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
10/27
08:04 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 23 Filed by: RA Capital Healthcare Fund LP
Medium Report
Form 4 Vor Biopharma Inc. For: Oct 23 Filed by: RA Capital Healthcare Fund LP
Report
10/22
07:48 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 20 Filed by: Shah Rajeev M.
Medium Report
Form 4 Vor Biopharma Inc. For: Oct 20 Filed by: Shah Rajeev M.
Report
10/21
05:45 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 17 Filed by: Hoffman Reid
Medium Report
Form 4 Vor Biopharma Inc. For: Oct 17 Filed by: Hoffman Reid
Report
10/20
07:02 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
10/20
05:26 pm
vor
Form 144 Vor Biopharma Inc. Filed by: RA Capital Nexus Fund, L.P.
Medium Report
Form 144 Vor Biopharma Inc. Filed by: RA Capital Nexus Fund, L.P.
Report
10/20
05:26 pm
vor
Form 144 Vor Biopharma Inc. Filed by: RA Capital Healthcare Fund LP
Medium Report
Form 144 Vor Biopharma Inc. Filed by: RA Capital Healthcare Fund LP
Report
10/17
06:36 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: Reprogrammed Interchange LLC
Medium Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: Reprogrammed Interchange LLC
Report
10/17
06:33 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 15 Filed by: Hoffman Reid
Medium Report
Form 4 Vor Biopharma Inc. For: Oct 15 Filed by: Hoffman Reid
Report
10/17
06:03 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 15 Filed by: Shah Rajeev M.
Low Report
Form 4 Vor Biopharma Inc. For: Oct 15 Filed by: Shah Rajeev M.
Report
10/17
05:14 pm
vor
Form 144 Vor Biopharma Inc. Filed by: RA Capital Nexus Fund, L.P.
Low Report
Form 144 Vor Biopharma Inc. Filed by: RA Capital Nexus Fund, L.P.
Report
10/17
05:11 pm
vor
Form 144 Vor Biopharma Inc. Filed by: RA Capital Healthcare Fund LP
Low Report
Form 144 Vor Biopharma Inc. Filed by: RA Capital Healthcare Fund LP
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2025, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0